|Articles|January 18, 2002
CDER News 1/7/02
Author(s)BioPharm International Editors
Drug approvals for 2001 and new approvals
Advertisement
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
3
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
4
Cellares Extends Cell Therapy Automation Beyond T Cell Therapies
5